Fierce Pharma

MARCH 23, 2023

AbbVie's Skyrizi aces ulcerative colitis study en route to new IBD showdown with J&J, Takeda aliu Thu, 03/23/2023 - 10:23

223

223

MedCity News

MARCH 23, 2023

GrayMatters Health recently received 510(k) clearance from the FDA to market its flagship product, which is a self-neuromodulation digital therapy for PTSD. The device uses neurofeedback on specific biomarkers to help patients identify and utilize their own mental strategy for lowering their emotional response.

FDA 123

FDA Marketing Patients 123

Fierce Pharma

MARCH 23, 2023

Fierce Pharma Asia—Takeda's $4B psoriasis data; Biohaven's neurology bet; Pfizer and Astellas' Xtandi wins aliu Thu, 03/23/2023 - 18:29

Pharma 198

Pharma 198

MedCity News

MARCH 23, 2023

Holon Solutions CEO Jon Zimmerman thinks more payers should invest in new technology to improve workloads for healthcare workers. The burnout crisis is too big for providers to solve by themselves, and many of the economic incentives for driving quality and efficiency in healthcare are housed within health plans and accountable care organizations, he said.

Healthcare 122

Healthcare Healthcare 122

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution

Fierce Pharma

MARCH 23, 2023

England's NICE signs off on PTC Therapeutics' $3.

219

219

MedCity News

MARCH 23, 2023

Conducted by researchers at the University of Colorado medical school, the new report is the latest to gauge the extent of a costly problem that federal regulators are working to solve: Information about doctors varies from provider directory to provider directory.

Insurance 114

Insurance Doctors Medical 114

MedCity News

MARCH 23, 2023

Of the more than 15% of American adults who have past-due medical debt, about 73% owe some or all of the money to hospitals, according to a recent Urban Institute report. The American Hospital Association said short-term limited duration health plans and high-deductible health plans are to blame.

Medical 108

Medical 108

Pharmaceutical Technology

MARCH 23, 2023

Biohaven has purchased the exclusive global rights for oral, brain-penetrant dual Tyrosine Kinase 2 (TYK2)/Janus Kinase 1 (JAK1) inhibitor, BHV-8000 (previously TLL-041), which treats immune-mediated brain disorders , from Hangzhou Highlightll Pharmaceutical. The deal gives Biohaven global rights for the development of BHV-8000, excluding regions of China.

Safety 105

Safety Pharmaceutical 105

MedCity News

MARCH 23, 2023

At the AHIP Medicare, Medicaid, Duals and Commercial Markets Forum held last week, two healthcare leaders from the Centers for Medicare and Medicaid Services (CMS) and CVS Health stressed that reducing maternal health disparities is a top priority, with several strategies at play. For CMS, the focus is on encouraging states to extend Medicaid postpartum coverage, while CVS Health is working to leverage doulas in their care delivery.

Healthcare 100

Healthcare Healthcare Marketing 100

Medgadget

MARCH 23, 2023

Researchers at Eindhoven University of Technology in the Netherlands have developed a sensitive diagnostic test for viral pathogens that is suitable for use in low-resource regions. The test is based on CRISPR proteins that can detect viral genetic material but also incorporates luciferase proteins, which are bioluminescent proteins that are naturally found in fireflies and other creatures.

Healthcare 97

Healthcare Healthcare Medicine 97

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

MedCity News

MARCH 23, 2023

Alzheimer’s disease research at MIT spawned Cognito Therapeutics, a startup whose medical device uses light and sound to modulate electrical activity that supports brain health. The company’s Series B financing will support a Phase 3 test of its technology in patients with mild-to-moderate disease.

Medical 90

Medical Patients Biopharma 90

European Pharmaceutical Review

MARCH 23, 2023

Key data from the BOREAS Phase III trial, the first out of two Phase III trials in the Dupixent ® (dupilumab) development programme, has shown that o f 939 adult patients, 30 percent experienced reduction in moderate or severe acute chronic obstructive pulmonary disease (COPD) exacerbations over 52 weeks. The fully human monoclonal antibody is the first and only biologic to demonstrate significant improvements in lung function.

Safety 78

Safety Patients Pharmaceutical 78

Modus

MARCH 23, 2023

B2B selling has drastically shifted over the past few years. Remote working environments, buyer-driven sales processes, omnichannel selling - the list goes on. And sales and marketing alignment becomes more important than ever. Given the many changes, it’s important to hone in on some of the key traits of successful sellers.

Sales process 72

Sales process Sales Marketing 72

PharmaTimes

MARCH 23, 2023

Eladocagene exuparvovec is for children with ultra-rare genetic disorder in final draft guidance

96

96

Advertisement

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

Specialization

European Pharmaceutical Review

MARCH 23, 2023

Through its investment of approximately £600 million, Takeda plans to build a new manufacturing facility for plasma-derived therapies (PDTs) in Osaka, Japan. This is Takeda’s largest ever investment in manufacturing capacity expansion and will be the largest facility of its kind in Japan. This is Takeda’s largest ever investment in manufacturing capacity expansion and will be the largest facility of its kind in Japan.” “The new facility will provide a plasma fractionation capacity of more

Manufacturing 61

Manufacturing Networking Medicine Medical 61

PharmaTimes

MARCH 23, 2023

The partnership will involve progressing macrophage-targeting antibody treatment for cancer

89

89

Copyright Clearance Center

MARCH 23, 2023

The post U.S. Copyright Office Launches AI Initiative, Including New Registration Guidance appeared first on Copyright Clearance Center.

71

71

Pharmaceutical Technology

MARCH 23, 2023

Pfizer recently announced an agreement to acquire Seagen, a biotech company based in the US with four marketed oncology therapeutic agents and a rich pipeline. The deal, expected to be completed by the end of 2023, will see Pfizer pay $229 per Seagen share in cash for a total of $43bn, the largest deal for the sector in the past three years. Seagen specialises in developing antibody-drug conjugates (ADCs) which will complement Pfizer’s oncology portfolio.

Engineering 59

Engineering Sales Patients Marketing 59

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Safety

Scott’s Directories

MARCH 23, 2023

Lead generation has created quite a buzz amongst marketers and business owners. As popular as it might be getting, its efficiency still depends on coming up with a robust, comprehensive strategy. How is a lead generation strategy created? How can lead generation companies help transform the way businesses sell their products and services, especially healthcare lead generation companies ?

Leads 52

Leads Media Healthcare Healthcare 52

Pharmaceutical Technology

MARCH 23, 2023

This week, the Medicines and Healthcare products Regulatory Agency (MHRA) is introducing major changes to clinical trial regulation in the UK with expedited timelines at several stages. The MHRA hopes this new framework “will remove obstacles to innovation” and “streamline the regulation of clinical trials” amongst other things. These changes come following a public consultation with the Healthcare Research Authority, to which a government response was published on March 21.

Healthcare 59

Healthcare Healthcare Recruitment Government 59

PharmaTech

MARCH 23, 2023

Wurster Fluid Bed Coating is one of the most utilized processes for microencapsulation of fine particles in pharmaceutical, dietary supplement, food, and other industries. Jared McDonald walks through a brief history of the invention of the process, what it is, and how it can be used to address specific needs for a product. A discussion of the importance of choosing an experienced CDMO follows.

Manufacturing 52

Manufacturing Food Pharmaceutical 52

Pharmaceutical Technology

MARCH 23, 2023

The biotech initial public offering (IPO) market saw a 79% decline in the number of completed IPOs from 2021 to 2022 in the US; however, this comes after the IPO boom in 2020 and 2021, according to GlobalData’s Pharma Intelligence Center Deals Database. An initial public offering is a process in which a private company sells its shares on the stock exchange to become public.

Marketing 59

Marketing Pharma Medicine Management 59

Advertisement

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

Management

Pharma Marketing Network

MARCH 23, 2023

Healthcare conferences have undergone significant changes since 2020 due to the COVID-19 pandemic. Prior to the pandemic, healthcare conferences were typically large in-person events, attracting thousands of attendees from around the world. However, with the outbreak of the virus and the need for social distancing, traditional in-person events have been disrupted, forcing the healthcare industry to find new ways to connect, share information, and collaborate.

Pharmaceutical 52

Pharmaceutical Healthcare Healthcare Networking 52

PharmaVoice

MARCH 23, 2023

The clinical data space is rapidly changing the face of the industry, GSK's Mayank Anand said — and the way organizations adopt technology is a critical part of the equation.

52

52

Pharma Marketing Network

MARCH 23, 2023

Pharmaceutical companies have made major strides in developing new treatments for Alzheimer’s disease, offering hope for the millions of people affected by this debilitating condition. Alzheimer’s is a progressive brain disorder that destroys memory and cognitive abilities, and currently there is no cure. However, recent advancements in research have resulted in new drugs that show promising results in slowing the progression of the disease.

Food and Drug Administration 52

Food and Drug Administration FDA Pharma Patients 52

Progressive Medical

MARCH 23, 2023

Progressive Medical Awarded National Agreement with Premier Inc. PMI is pleased to announce that it has been awarded a […] The post Progressive Medical, Inc. Awarded Drug Reconstitution and Transfer Devices Agreement with Premier, Inc. appeared first on Progressive Medical, Inc.

Medical 52

Medical 52

Advertisement

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

Leads

Pharma Marketing Network

MARCH 23, 2023

Pharmaceutical advertising is a crucial aspect of promoting and marketing drugs to the public. With the increase in competition, it has become essential for pharmaceutical companies to find the most effective methods of advertisement to reach their target audience. In this article, we will discuss the most effective types of advertisement in the pharmaceutical industry and provide examples and statistics to support our findings. 1.

Pharma 52

Pharma Side effects Education Pharmaceutical 52

Pharma Leaders

MARCH 23, 2023

Dewpoint Therapeutics has formed a research and development partnership with Novo Nordisk for identifying drug candidates to treat insulin resistance and diabetic complications. Dewpoint’s discovery platform related to biomolecular condensates will be used to identify the drug candidates. The collaboration will enable combination of Novo Nordisk’s expertise in treating diabetes and metabolic diseases and Dewpoint’s discovery and artificial intelligence (AI) technology platform to detect modulato

Sales 52

Sales Leads 52

Pharma Marketing Network

MARCH 23, 2023

The Food and Drug Administration (FDA) has recently approved a new drug for the treatment of Alzheimer’s disease called Leqembi. This approval marks a major milestone in the fight against Alzheimer’s, which is the sixth leading cause of death in the United States and affects over 5 million people. Leqembi, developed by pharmaceutical company Biohaven, is an oral treatment that is designed to target the root cause of Alzheimer’s, which is the accumulation of a protein called bet

Food and Drug Administration 52

Food and Drug Administration FDA Consulting Food 52

Pharmaceutical Technology

MARCH 23, 2023

China’s National Medical Products Administration (NMPA) has granted emergency use authorisation (EUA) for CSPC Pharmaceutical Group’s messenger RNA (mRNA) vaccine, SYS6006, to treat Covid-19. With this regulatory approval, CSPC Pharmaceutical is claimed to be the first company to receive approval for providing an mRNA vaccine in the country. The latest authorisation from the Chinese health authority comes as cases of Covid-19 decline after a recent surge.

Pharmaceutical 52

Pharmaceutical Safety Leads Medical 52

Advertisement

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.

Patients